Insider Transactions in Q3 2023 at Vertex Pharmaceuticals Inc (VRTX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2023
|
Jonathan Biller EVP and Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
408
-3.52%
|
$142,800
$350.72 P/Share
|
|
Sep 19
2023
|
Carmen Bozic EVP and CMO |
SELL
Open market or private sale
|
Direct |
5,651
-9.82%
|
$1,983,501
$351.0 P/Share
|
|
Sep 05
2023
|
Carmen Bozic EVP and CMO |
SELL
Open market or private sale
|
Direct |
5,651
-8.94%
|
$1,989,152
$352.66 P/Share
|
|
Aug 23
2023
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
SELL
Open market or private sale
|
Direct |
2,500
-4.89%
|
$887,500
$355.0 P/Share
|
|
Aug 10
2023
|
Terrence C Kearney Director |
SELL
Open market or private sale
|
Direct |
10,000
-60.47%
|
$3,500,000
$350.0 P/Share
|
|
Aug 10
2023
|
Terrence C Kearney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+37.68%
|
$1,270,000
$127.54 P/Share
|
|
Aug 10
2023
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
SELL
Open market or private sale
|
Direct |
10,031
-14.57%
|
$3,510,850
$350.0 P/Share
|
|
Aug 10
2023
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
SELL
Open market or private sale
|
Direct |
5,750
-10.11%
|
$1,983,750
$345.79 P/Share
|
|
Aug 09
2023
|
Sangeeta N. Bhatia Director |
SELL
Open market or private sale
|
Direct |
242
-5.23%
|
$83,490
$345.51 P/Share
|
|
Aug 09
2023
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
63
-0.2%
|
$21,735
$345.51 P/Share
|
|
Jul 17
2023
|
Bruce I Sachs Director |
SELL
Open market or private sale
|
Direct |
11,250
-7.87%
|
$4,005,000
$356.53 P/Share
|
|
Jul 17
2023
|
Bruce I Sachs Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,250
+18.0%
|
$1,428,750
$127.54 P/Share
|
|
Jul 17
2023
|
Reshma Kewalramani CEO & President |
SELL
Open market or private sale
|
Direct |
7,828
-6.18%
|
$2,778,940
$355.0 P/Share
|